The Age-Related Eye Disease Study (AREDS) is a major clinical trial sponsored by the National Eye Institute (NEI), a part of the National Institutes of Health (NIH). The purpose of this study was to learn more about the natural history and risk factors of age-related macular degeneration (AMD) and to evaluate the effect of high doses of…
OCT is a non-invasive technology used for imaging the retina. This is the first instrument that allows doctors to see cross-section images of the retina, and is revolutionizing the early detection and treatment of retinal conditions such as: macular edema, macular holes and optic nerve damage. OCT is a non-invasive technology used for imaging the…
The National Eye Institute (NEI) of the National Institutes of Health (NIH) announces the start of a multicenter clinical trial to compare the relative safety and effectiveness of two drugs currently used to treat advanced age-related macular degernation (AMD). The two drugs, Lucentis (ranibizumab) and Avastin (bevacizumab). AMD is a disease that damages the macula.…